Results 201 to 210 of about 262,063 (357)
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga+8 more
wiley +1 more source
OXA-48-like carbapenemases: the phantom menace.
L. Poirel, A. Potron, P. Nordmann
semanticscholar +1 more source
YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy+9 more
wiley +1 more source
Development of a deep learning based approach for multi-material decomposition in spectral CT: a proof of principle in silico study. [PDF]
Rajagopal JR+11 more
europepmc +1 more source
Improved cardiac anthropomorphic phantom. [PDF]
Stephen W. Smith+3 more
openalex +1 more source
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern+7 more
wiley +1 more source
Preclinical dose assessment of cyberknife with small animal intracranial irradiation using a 3D printed mouse phantom. [PDF]
Liu X+6 more
europepmc +1 more source
The Production and Evaluation of the Tissue-equivalent Phantom for the Magnetic Resonance Imaging [PDF]
Young Hoon Ryu+4 more
openalex +1 more source